2023/07/19 ALA-1300 Received the patent, LONG-ACTING INJECTABLE FORMULATIONS AND CRYSTALLINE FORMS OF BUPRENORPHINE DERIVATIVES , from Directorate General of Intellectual Property Rights (DGIP) of Indonesia, NO IDP 000 087828 B 26 . 7 . 2023 閱讀更多 » 2023/06/29 ALA-1000 Received the patent, SUSTAINED-RELEASE BUPRENORPHINE FORMULATIONS, from Intellectual Property Corporation of Malaysia (MyIPO) , NO : MY-196269-A 30 . 6 . 2023 閱讀更多 » 2022/12/29 ALA -1300 Received notice of patent allowance from the Mexican Institute of Industrial Property (IMPI), NO: MX/a/2020/008471 1 . 2 . 2023 閱讀更多 » 2022/12/05 ALA-1000 received notice of patent allowance from Companies and Intellectual Property Commission of Republic of South Africa , Application No. 2020/04582 6 . 12 . 2022 閱讀更多 » 2022/11/21 ALA-1000 received notice of patent allowance from China National Intellectual Property Administration, Application No. 201780055635.3 21 . 11 . 2022 閱讀更多 » « 上一頁 Page1 Page2 Page3 Page4 Page5 下一頁 »
2023/07/19 ALA-1300 Received the patent, LONG-ACTING INJECTABLE FORMULATIONS AND CRYSTALLINE FORMS OF BUPRENORPHINE DERIVATIVES , from Directorate General of Intellectual Property Rights (DGIP) of Indonesia, NO IDP 000 087828 B 26 . 7 . 2023 閱讀更多 »
2023/06/29 ALA-1000 Received the patent, SUSTAINED-RELEASE BUPRENORPHINE FORMULATIONS, from Intellectual Property Corporation of Malaysia (MyIPO) , NO : MY-196269-A 30 . 6 . 2023 閱讀更多 »
2022/12/29 ALA -1300 Received notice of patent allowance from the Mexican Institute of Industrial Property (IMPI), NO: MX/a/2020/008471 1 . 2 . 2023 閱讀更多 »
2022/12/05 ALA-1000 received notice of patent allowance from Companies and Intellectual Property Commission of Republic of South Africa , Application No. 2020/04582 6 . 12 . 2022 閱讀更多 »
2022/11/21 ALA-1000 received notice of patent allowance from China National Intellectual Property Administration, Application No. 201780055635.3 21 . 11 . 2022 閱讀更多 »
